ACCUFIT A282

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 00 report with the FDA on 2001-03-09 for ACCUFIT A282 manufactured by Beltone Electronics Corp..

Event Text Entries

[16263425] The hearing aid (h/a) user reported bleeding of the skin of the outer ear after having an earmold impression taken by the hearing aid dispenser. The user sought help from their physician to treat the ear.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1416900-2000-00131
MDR Report Key319822
Report Source00
Date Received2001-03-09
Date of Report2000-04-21
Date of Event2000-04-01
Date Mfgr Received2000-04-21
Date Added to Maude2001-03-14
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer ContactCLIFF LONG
Manufacturer Street4201 WEST VICTORIA STREET
Manufacturer CityCHICAGO IL 60646
Manufacturer CountryUS
Manufacturer Postal60646
Manufacturer Phone7735833600
Manufacturer G1*
Manufacturer Street*
Manufacturer City*
Manufacturer Country*
Single Use3
Remedial ActionOT
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameACCUFIT
Generic NameIMPRESSION MATERIAL
Product CodeLDG
Date Received2001-03-09
Model NumberNA
Catalog NumberA282
Lot NumberNA
ID NumberNA
OperatorLAY USER/PATIENT
Device AvailabilityN
Device Eval'ed by MfgrN
Implant FlagN
Date RemovedA
Device Sequence No1
Device Event Key309353
ManufacturerBELTONE ELECTRONICS CORP.
Manufacturer Address4201 WEST VICTORIA STREET CHICAGO IL 60646 US
Baseline Brand NameACCUFIT
Baseline Generic NameIMPRESSION MATERIAL
Baseline Model NoNA
Baseline Catalog NoA282
Baseline IDNA
Baseline Device FamilyKIT, EARMOLD IMPRESSION
Baseline Shelf Life ContainedY
Baseline Shelf Life [Months]12
Baseline PMA FlagN
Baseline 510K PMNY
Premarket NotificationK963958
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2001-03-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.